These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. A comparison of the bronchodilating effects of a beta-2 adrenergic agent (albuterol) and an anticholinergic agent (ipratropium bromide), given by aerosol alone or in sequence. Easton PA, Jadue C, Dhingra S, Anthonisen NR. N Engl J Med; 1986 Sep 18; 315(12):735-9. PubMed ID: 2943994 [Abstract] [Full Text] [Related]
27. Bronchodilator therapy in chronic airflow obstruction. Niewoehner DE, Leatherman JW. Chest; 1984 Aug 18; 86(2):161-2. PubMed ID: 6146498 [No Abstract] [Full Text] [Related]
28. [Drug treatment of chronic obstructive pulmonary disease]. van Herwaarden CL, Dekhuijzen PN, van Schayck CP, van Weel C, Molema J. Ned Tijdschr Geneeskd; 1996 Apr 06; 140(14):761-5. PubMed ID: 8668261 [No Abstract] [Full Text] [Related]
29. Evidence based answers--is salmeterol safe in asthma? Spurling G, Doust J. Aust Fam Physician; 2006 Aug 06; 35(8):625-6. PubMed ID: 16894440 [No Abstract] [Full Text] [Related]
30. [Clinical aspects of anticholinergic agents]. Friedman M. Rev Mal Respir; 1998 Sep 06; 15 Suppl 2():S51-4. PubMed ID: 9809345 [No Abstract] [Full Text] [Related]
31. [The validation and procedure of inhalation therapy using 2-component aerosols in obstructive bronchopulmonary diseases]. Ivashkin VT, Iakovlev VN, Sinopal'nikov AI, Antokhin EA. Ter Arkh; 1993 Sep 06; 65(8):44-9. PubMed ID: 8211802 [No Abstract] [Full Text] [Related]
32. New concepts in bronchodilator therapy. Owens GR. Am Fam Physician; 1986 Jan 06; 33(1):218-29. PubMed ID: 2934965 [No Abstract] [Full Text] [Related]
33. [Salmeterol + fluticasone in COPD. Complementary treatment principles hold true in the COPD management, too]. MMW Fortschr Med; 2003 Nov 13; 145(46):47. PubMed ID: 14699834 [No Abstract] [Full Text] [Related]
34. Important aspects of pulmonary rehabilitation. McDonald GJ, Hudson LD. Geriatrics; 1982 Mar 13; 37(3):127-32, 134. PubMed ID: 6121740 [No Abstract] [Full Text] [Related]
35. New developments in bronchodilator therapy. Nelson HS. Curr Opin Pulm Med; 1996 Jan 13; 2(1):35-9. PubMed ID: 9363113 [Abstract] [Full Text] [Related]
36. The treatment of asthma. Part 2. Practical aspects of management. Paterson JW, Tarala RA. Med J Aust; 1985 Nov 11; 143(10):453-5. PubMed ID: 2868403 [No Abstract] [Full Text] [Related]
37. An evaluation of nebulized levalbuterol in stable COPD. Datta D, Vitale A, Lahiri B, ZuWallack R. Chest; 2003 Sep 11; 124(3):844-9. PubMed ID: 12970007 [Abstract] [Full Text] [Related]
38. Bronchodilator resuscitation in the emergency department. Part 2 of 2: dosing strategies. Fink J, Dhand R. Respir Care; 2000 May 11; 45(5):497-512. PubMed ID: 10813227 [No Abstract] [Full Text] [Related]
39. Drugs for asthma. Med Lett Drugs Ther; 1999 Jan 15; 41(1044):5-10. PubMed ID: 9930206 [No Abstract] [Full Text] [Related]
40. The impact of combined inhaled bronchodilator therapy in the treatment of COPD. Benayoun S, Ernst P, Suissa S. Chest; 2001 Jan 15; 119(1):85-92. PubMed ID: 11157588 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]